Luxury skincare brand Cha Ling has closed all its physical stores in China to optimize its retail strategy as Covid-19 disruptions continue
The LVMH-owned Cha Ling, which operated stores in China for five years, also shut down its WeChat online store.
The brand will continue to sell its products across LVMH’s Sephora China stores as an exclusive brand. It will also retain its Tmall store.
Cha Ling entered China in 2017, a year after it was founded by Laurent Boillot, who is currently CEO of Hennessy.
Since then, the brand has opened three stores in the country: Shanghai HKRI Taikoo Hui, Shanghai IFC, and Hangzhou’s MixC Mall.
The LVMH-owned luxury skincare label is known for blending Eastern and Western cultures through its brand philosophy of "Beauty with a meaning, for you, for the others, and the world."
Cha Ling joins a series of brands closing stores in China, such as L’Oreal-owned beauty brand Maybelline, due to the uncertainty of the Covid-19 situation.


Eli Lilly Eyes AtaiBeckley Acquisition to Expand Psychedelic Mental Health Pipeline
FDA Weighs Safety Standards for Psychedelic Therapies
Hims & Hers Shares Fall as GLP-1 Costs Widen Q2 Loss
AstraZeneca Halts Phase III Volrustomig Lung Cancer Trial After Efficacy Setback
‘Buy now, pay later’ doesn’t feel like debt. For young people, that can be a big problem
Novo Nordisk Eyes Turnaround as Oral Wegovy Challenges Eli Lilly in Weight-Loss Drug Race
Fed Unveils Stablecoin Rules Under GENIUS Act
Britain has almost 1 million young people not in work or education – here’s what evidence shows can change that
Oil Prices Jump 3% as Houthi Attack Revives Supply Fears
How to support someone who is grieving: five research-backed strategies
Oil Prices Ease as Iran Tensions Clash With Diplomacy Hopes
Soybean Futures Slip as Traders Await Trump-Xi Trade Signals
Suzuki Targets Faster Car Development to Keep Pace With Chinese Rivals
3 clinical-grade skincare creams you really shouldn’t buy online
Mexico-US Trade Talks Delayed to October as Tariff Negotiations Continue
Novo Nordisk Strikes €1.17 Billion Nanexa Drug Delivery Deal
Canadian Dollar Faces Pressure as Fed-BoC Policy Gap Widens 



